| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
ziprasidone hydrochloride
|
122883-93-6 |
5-[2-[4-(1,2-苯并异噻唑-3-基)-1-哌嗪基]乙基]-6-氯-1,3-二氢-2H-吲哚-2-酮
|
盐酸齐哌西酮;5-[2-[4-(1,2-苯并异噻唑-3-基)-1-哌嗪基]乙基]-6-氯-1,3-二氢-2H-吲哚-3-酮盐酸盐;佐帕司通盐酸盐
|
C21H21ClN4OS.HCl |
449.4 | 602-903-0 |
|
Taranabant
|
701977-09-5 |
N-[(1S,2S)-3-(4-氯苯基)-2-(3-氰基苯基)-1-甲基丙基]-2-甲基-2-[(5-(三氟甲基)吡啶-2-基)氧基]丙酰胺
|
N-[(1S,2S)-3-(4-氯苯基)-2-(3-氰基苯基)-1-甲基丙基]-2-甲基-2-[(5-(三氟甲基)吡啶-3-基)氧基]丙酰胺;泰伦那班
|
C27H25ClF3N3O2 |
515.95 | |
|
P505-15
|
1370261-96-3 |
2-[[(1R,2S)-2-氨基环己基]氨基]-4-[[3-(2H-1,2,3-三唑-2-基)苯基]氨基]-5-嘧啶甲酰胺
|
2-[[(1R,2S)-2-氨基环己基]氨基]-4-[[3-(2H-1,2,3-三唑-2-基)苯基]氨基]-5-嘧啶甲酰胺;PRT062607;P505-15;BIIB-057
|
C19H23N9O |
393.44562 | |
|
Shz-1
|
326886-05-9 |
苯磺酸[(5-溴-2-羟基苯基)亚甲基]酰肼
|
苯磺酸[(5-溴-2-羟基苯基)亚甲基]酰肼
|
C13H11BrN2O3S |
355.20704 | |
|
ICG-001
|
780757-88-2 |
ICG-001
|
2,3-二氢-1,4-苯并恶嗪;ICG-001;ICG001;(6S,9AS)-6-(4-HYDROXYBENZYL)-N-BENZYL-8-(NAPHTHALEN-1-YLMETHYL)-4,7-DIOXO-HEXAHYDRO-2H-PYRAZINO[1,2-A]PYRIMIDINE-1(6H)-CARBOXAMIDE;(6R,9AR)-REL-六氢-6-[(4-羟基苯基)甲基]-8-(1-萘基甲基)-4,7-二氧代-N-(苯基甲基)-2H-吡嗪并[1,2-A]嘧啶-1(6H)-甲酰胺
|
C33H32N4O4 |
548.64 | |
|
rac-Rotigotine Hydrochloride
|
102120-99-0 |
5,6,7,8-四氢-6-[丙基[2-(2-噻吩基)乙基]氨基]-1-萘酚盐酸盐
|
5,6,7,8-四氢-6-[丙基[2-(2-噻吩基)乙基]氨基]-1-萘酚盐酸盐;盐酸罗替高汀;消旋罗替戈汀;罗替高汀-D7盐酸
|
C19H26ClNOS |
351.93384 | |
|
2-PHENYLTHIO-5-PROPIONYL PHENYL ACETIC ACID
|
92321-29-4 |
2-苯硫基-5-丙酰基苯乙酸
|
2-苯硫基-5-丙酰基苯乙酸;2-苯基-2-(1-哌啶基)丙烷;1-(1-METHYL-1-PHENYLETHYL)PIPERIDINE;1-(Α;Α-DIMETHYLBENZYL)PIPERIDINE;1-(1-甲基-1-苯基乙基)哌啶;1-(2-苯基丙烷-2-基)哌啶;聚(2,5-双(3-磺酸基丙氧基)-1,4-苯撑,二钠盐-ALT-1,4-苯撑)
|
C17H16O3S |
300.37 | |
|
DR 2313
|
284028-90-6 |
3,5,7,8-四氢-2-甲基-4H-硫代吡喃并[4,3-D]嘧啶-4-酮
|
3,5,7,8-四氢-2-甲基-4H-硫代吡喃并[4,3-D]嘧啶-4-酮,98%;3,3-D]嘧啶-4-酮;7,8-二氢-2-甲基-1H-噻喃[4,3-D]嘧啶-4(5H)-酮;1,8-四氢-2-甲基-4H-硫代吡喃[4,3-D]嘧啶-4-酮;4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE,8-TETRAHYDRO-2-METHYL-
|
C8H10N2OS |
182.2428 | 200-589-5 |
|
L 2-401
|
883050-24-6 |
4-[(4-氟苯基)甲基]-2-(4-甲基苯基)-1,2,4-噻二唑烷-3,5-二酮
|
CS-563;CCG50014;CCG 50014;4-[(4-氟苯基)甲基]-2-(4-甲基苯基)-1,2,4-噻二唑烷-3,5-二酮
|
C16H13FN2O2S |
316.350023 | |
|
JNK-IN-8
|
1410880-22-6 |
JNK-IN-8
|
3-[[4-(二甲基氨基(-1-氧代-2-丁烯-1-基]氨基]-N-[3-甲基-4-[[4-(3-吡啶基(-2-嘧啶基]氨基]苯基]苯甲酰胺;CS-1339
|
C29H29N7O2 |
507.58626 | |
|
6-Nitro-benzo[b]thiophene 1,1-dioxide
|
19983-44-9 |
Stattic
|
6-硝基-1-苯并噻吩1,1-二氧化物;6-硝基-1H-1LAMBDA~6~-苯并[B]噻吩-1,1-二酮;STATTIC盐;CS-1523
|
C8H5NO4S |
211.19 | |
|
GSK J1
|
1373422-53-7 |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸
|
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸;GSK J1(锂盐);CS-2305
|
C22H23N5O2 |
389.45032 | 200-258-5 |
|
Aurora A Inhibitor I
|
1158838-45-9 |
Aurora A Inhibitor I
|
N-(2-氯苯基)-4-[[2-[[4-[2-(4-乙基-1-哌嗪基)-2-氧代乙基]苯基]氨基]-5-氟-4-嘧啶基]氨基]苯甲酰胺
|
C31H31ClFN7O2 |
588.0749432 | |
|
(4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE
|
85416-73-5 |
S- (+)-Rolipram
|
(+)-ROLIPRAM;(S)-ROLIPRAM;(S)-4-[3-(环戊基氧基)-4-甲氧基苯基]-2-吡咯烷酮;S-(+)-咯利普兰
|
C16H21NO3 |
275.34 | |
|
Vonoprazan FuMarate
|
881681-01-2 |
富马酸沃诺拉赞
|
富马酸凡诺帕胺;TAK-438(富马酸沃诺拉赞);富马酸氟呐普拉赞;富马酸氟呐普拉赞(TAK-438);文诺普兰标准品LT1
|
C21H20FN3O6S |
461.463403 | 1592732-453-0 |
|
VX-661
|
1152311-62-0 |
1-(2,2-二氟-1,3-苯并二氧戊环-5-基)-N-[1-[(2R)-2,3-二羟基丙基]-6-氟-2-(2-羟基-1,1-二甲基乙基)-1H-吲哚-5-基]-环丙烷甲酰胺
|
VX 661;VX661;VX-661;VX 661;VX661;VX-661;TEZACAFTOR;CS-956;1-(2,2-二氟-1,3-苯并二氧戊环-5-基)-N-[1-[(2R)-2,3-二羟基丙基]-6-氟-2-(2-羟基-1,1-二甲基乙基)-1H-吲哚-5-基]-环丙烷甲酰胺
|
C26H27F3N2O6 |
520.4975896 | |
|
MPEP HYDROChloride
|
219911-35-0 |
2-甲基-6-(苯基乙炔基)吡啶盐酸盐
|
2-甲基-6-苯基乙炔基吡啶盐酸盐;2-甲基-6-(苯基乙炔基)吡啶盐酸盐;MPEP盐酸盐>98%
|
C14H11N.ClH |
229.709 | |
|
Lapatinib ditosylate
|
388082-78-8 |
二甲苯磺酸拉帕替尼
|
二对苯甲磺酸拉帕替尼;N-(3-氯-4-((3-氟苯基)甲氧基)苯基)-6-(5-(((2-(甲磺酰基)乙基)氨基)甲基)-2-呋喃基)-4-喹唑啉胺二对甲苯磺酸盐水合物;GW-572016;GW572016;二甲苯磺酸拉帕替尼;N-(3-氯-4-((3-氟苯基)甲氧基)苯基)-6-(5-(((2-(甲磺酰基)乙基)氨基)甲基)-2-呋喃基)-4-喹唑啉胺二对甲苯磺酸盐;二对甲苯磺酸拉帕替尼;拉帕替尼二甲苯磺酰酸盐;二甲苯磺酸拉帕替尼;二对甲苯磺酸拉帕替尼;N-(3-氯-4-((4-氟苯基)甲氧基)苯基䀀✀Calibri
|
C43H42ClFN4O10S3 |
925.46 | 642-915-3 |
|
Vandetanib
|
443913-73-3 |
凡德他尼
|
范得他尼;ZD6474;ZD-6474;ZD 6474;凡他尼布;凡德它尼;凡德他尼及中间体;ZD6474;ZACTIMA;4-(4-溴-2-氟苯胺基)-6-甲氧基-7-[(1-甲基哌啶-4-基)甲氧基]喹唑啉
|
C22H24BrFN4O2 |
475.35 | 669-841-4 |
|
Dorzolamide Hydrochloride
|
130693-82-2 |
盐酸多佐胺
|
盐酸杜塞酰胺;盐酸多佐胺;盐酸多佐胺及中间体;盐酸杜塞酰胺(标准品);(2S,4S)-2-乙基氨基-4-甲基-5,5-二氧-5,7-二硫双环[4.3.0]壬-8,10-二烯-8-磺酰胺盐酸盐;盐酸多佐胺(青光眼治疗药)
|
C10H17ClN2O4S3 |
360.9 | 620-304-2 |
药智官方微信
药智官方微博
